DMSCO was established in 1991, and its first pharmacy branch opened in 1993 in Al-Khobar, Saudi Arabia. In the first half of 2024, the company generated revenues of $827.4 million and recorded assets of $1.3 billion. In June 2024, DMSCO signed a strategic manufacturing agreement with Avalon Pharma to localize essential medication production in Saudi Arabia. Al-Farraj also serves as chairman of the Eastern Cement Company and the Kanaf Charity Organization.